Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review
João Lopes,1 Paulo Santos1,2 1Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal; 2CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, PortugalCorrespondence: João Lope...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-08-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/determinants-of-non-adherence-to-the-medications-for-dyslipidemia-a-sy-peer-reviewed-fulltext-article-PPA |
id |
doaj-1d303e8dcd564076b1364613e6817409 |
---|---|
record_format |
Article |
spelling |
doaj-1d303e8dcd564076b1364613e68174092021-08-24T20:06:35ZengDove Medical PressPatient Preference and Adherence1177-889X2021-08-01Volume 151853187168176Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic ReviewLopes JSantos PJoão Lopes,1 Paulo Santos1,2 1Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal; 2CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, PortugalCorrespondence: João LopesDepartment of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, Porto, 4200-319, PortugalTel +351 220426600Email joaomoraislopes@gmail.comPurpose: Dyslipidemia is a major cardiovascular risk factor, and its control leads to less cardiovascular events. Many patients will need some medications to achieve ideal targets. Non-adherence to medications is a complex problem with high impact on their effectiveness. This study aims to identify the determinants of non-adherence to medications in patients with dyslipidemia.Patients and Methods: We conducted a systematic review. PubMed and Scopus databases were searched for original articles, published between 2000 and 2020, using the MeSH terms “Dyslipidemias” and “Medication Adherence”.Results: From the initial 3502 identified articles, we selected 46 to include in the final qualitative synthesis. The determinants associated with non-adherence were lower age (≤ 50 years), female sex, African American ethnicity, smoking habits, being a new user of lipid-lowering medications, reporting or having concerns about lipid-lowering medication side effects and some comorbidities (chronic obstructive pulmonary disease, Alzheimer’s disease/dementia, depression and diabetes). On the contrary, adherence is higher in older patients, alcohol drinking habits, taking β-blockers, having a higher number of comorbidities, having a history of cardiovascular events, cardiac interventions or revascularization procedures, having health insurance and having more provider follow-up visits.Conclusion: There are important identifiable determinants of non-adherence in patients with dyslipidemia. These patients benefit from a specific approach to minimize the problem and maximize the potential benefit of the prescription.Keywords: medication adherence, dyslipidemias, causality, epidemiologic factors, heart disease risk factorshttps://www.dovepress.com/determinants-of-non-adherence-to-the-medications-for-dyslipidemia-a-sy-peer-reviewed-fulltext-article-PPAmedication adherencedyslipidemiascausalityepidemiologic factorsheart disease risk factors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lopes J Santos P |
spellingShingle |
Lopes J Santos P Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review Patient Preference and Adherence medication adherence dyslipidemias causality epidemiologic factors heart disease risk factors |
author_facet |
Lopes J Santos P |
author_sort |
Lopes J |
title |
Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review |
title_short |
Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review |
title_full |
Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review |
title_fullStr |
Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review |
title_full_unstemmed |
Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review |
title_sort |
determinants of non-adherence to the medications for dyslipidemia: a systematic review |
publisher |
Dove Medical Press |
series |
Patient Preference and Adherence |
issn |
1177-889X |
publishDate |
2021-08-01 |
description |
João Lopes,1 Paulo Santos1,2 1Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal; 2CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, PortugalCorrespondence: João LopesDepartment of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, Porto, 4200-319, PortugalTel +351 220426600Email joaomoraislopes@gmail.comPurpose: Dyslipidemia is a major cardiovascular risk factor, and its control leads to less cardiovascular events. Many patients will need some medications to achieve ideal targets. Non-adherence to medications is a complex problem with high impact on their effectiveness. This study aims to identify the determinants of non-adherence to medications in patients with dyslipidemia.Patients and Methods: We conducted a systematic review. PubMed and Scopus databases were searched for original articles, published between 2000 and 2020, using the MeSH terms “Dyslipidemias” and “Medication Adherence”.Results: From the initial 3502 identified articles, we selected 46 to include in the final qualitative synthesis. The determinants associated with non-adherence were lower age (≤ 50 years), female sex, African American ethnicity, smoking habits, being a new user of lipid-lowering medications, reporting or having concerns about lipid-lowering medication side effects and some comorbidities (chronic obstructive pulmonary disease, Alzheimer’s disease/dementia, depression and diabetes). On the contrary, adherence is higher in older patients, alcohol drinking habits, taking β-blockers, having a higher number of comorbidities, having a history of cardiovascular events, cardiac interventions or revascularization procedures, having health insurance and having more provider follow-up visits.Conclusion: There are important identifiable determinants of non-adherence in patients with dyslipidemia. These patients benefit from a specific approach to minimize the problem and maximize the potential benefit of the prescription.Keywords: medication adherence, dyslipidemias, causality, epidemiologic factors, heart disease risk factors |
topic |
medication adherence dyslipidemias causality epidemiologic factors heart disease risk factors |
url |
https://www.dovepress.com/determinants-of-non-adherence-to-the-medications-for-dyslipidemia-a-sy-peer-reviewed-fulltext-article-PPA |
work_keys_str_mv |
AT lopesj determinantsofnonadherencetothemedicationsfordyslipidemiaasystematicreview AT santosp determinantsofnonadherencetothemedicationsfordyslipidemiaasystematicreview |
_version_ |
1721197013276557312 |